Code | Display | Comments |
---|
207 | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose | |
208 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | |
210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | |
211 | COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL | |
212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | |
213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | |
217 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose | |
218 | COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose | |
219 | COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose | |
221 | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose | |
225 | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL | |
226 | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL | |
227 | COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose | |
228 | COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose | |
229 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose | |
230 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL | |
300 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose | |
301 | COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose | |
302 | COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose | |
500 | COVID-19 Non-US Vaccine, Product Unknown | |
501 | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) | |
502 | COVID-19 IV Non-US Vaccine (COVAXIN) | |
503 | COVID-19 LAV Non-US Vaccine (COVIVAC) | |
504 | COVID-19 VVnr Non-US Vaccine (Sputnik Light) | |
505 | COVID-19 VVnr Non-US Vaccine (Sputnik V) | |
506 | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology) | |
507 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) | |
508 | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) | |
509 | COVID-19 PS Non-US Vaccine (EpiVacCorona) | |
510 | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | |
511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | |
512 | SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | |
513 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | |
514 | SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | |
515 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | |
516 | COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | |
517 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | |
518 | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) | |
519 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna | |
520 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech | |